Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-individual titration study of cinacalcet (KRN1493) for hypercalcemia in parathyroid carcinoma or intractable primary hyperparathyroidism
jRCT2080221630Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cinacalcet in hypercalcemia, parathyroid cancer and primary hyperparathyroidism (PHPT), sponsored by Kyowa Kirin.
02
Drugs
cinacalcet
03
Conditions
hypercalcemiaparathyroid cancerprimary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on jRCT2080221630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221630.